Dorothy Ndishabandi

机构：Massachusetts General Hospital · ORCID：0000-0003-2985-8783

发表论文 13 篇 · 总被引 380 次 · h-index 9

代表论文

• Anti‐PD‐1/PD‐L1 therapy augments lenvatinib's efficacy by favorably altering the immune microenvironment of murine anaplastic thyroid cancer (2018 · International Journal of Cancer · 被引 114)
• Combinations of BRAF inhibitor and anti-PD-1/PD-L1 antibody improve survival and tumour immunity in an immunocompetent model of orthotopic murine anaplastic thyroid cancer (2018 · British Journal of Cancer · 被引 111)
• Novel intragraft regulatory lymphoid structures in kidney allograft tolerance (2021 · American Journal of Transplantation · 被引 40)
• Immunosuppression With CD40 Costimulatory Blockade Plus Rapamycin for Simultaneous Islet–Kidney Transplantation in Nonhuman Primates (2016 · American Journal of Transplantation · 被引 22)
• Presence of intramucosal neuroglial cells in normal and aganglionic human colon (2014 · American Journal of Physiology-Gastrointestinal and Liver Physiology · 被引 22)
• Depletion of Foxp3+ T Cells Abrogates Tolerance of Skin and Heart Allografts in Murine Mixed Chimeras Without the Loss of Mixed Chimerism (2014 · American Journal of Transplantation · 被引 21)